428
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data

, , , , &
Pages 261-268 | Received 22 Dec 2023, Accepted 07 May 2024, Published online: 24 May 2024

References

  • Castaman G, Linari S. Obstacles to early diagnosis and treatment of inherited von Willebrand disease: current perspectives. J Blood Med. 2021;12:165–175. doi: 10.2147/JBM.S232758
  • Favaloro EJ. Rare forms of von Willebrand disease. Ann Transl Med. 2018;6(17):345. doi: 10.21037/atm.2018.09.10
  • James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300. doi: 10.1182/bloodadvances.2020003265
  • Lavin M, O’Donnell JS. How I treat low von Willebrand factor levels. Blood. 2019;133(8):795–804. doi: 10.1182/blood-2018-10-844936
  • Colonne CK, Reardon B, Curnow J, et al. Why is misdiagnosis of von Willebrand disease still prevalent and how can we overcome it? A focus on clinical considerations and recommendations. J Blood Med. 2021;12:755–768. doi: 10.2147/JBM.S266791
  • Sidonio RF Jr, Zia A, Fallaize D. Potential undiagnosed VWD or other mucocutaneous bleeding disorder cases estimated from private medical insurance claims. J Blood Med. 2020;11:1–11. doi: 10.2147/JBM.S224683
  • Roberts JC, Kulkarni R, Kouides PA, et al. Healthcare utilization and health related quality of life in persons with von Willebrand disease. Blood. 2020;136(Supplement 1):3–4. doi: 10.1182/blood-2020-143055
  • Sidonio RF, Haley KM, Fallaize D. Impact of diagnosis of von Willebrand disease on patient outcomes: analysis of medical insurance claims data. Haemophilia. 2017;23(5):743–749. doi: 10.1111/hae.13292
  • Atiq F, Saes JL, Punt MC, et al. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 2021;32:100726. doi: 10.1016/j.eclinm.2021.100726
  • Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1. Haemophilia. 2008;14(2):171–232. doi: 10.1111/j.1365-2516.2007.01643.x
  • Ragni MV, Machin N, Malec LM, et al. Von Willebrand factor for menorrhagia: a survey and literature review. Haemophilia. 2016;22(3):397–402. doi: 10.1111/hae.12898
  • Kirtava A, Crudder S, Dilley A, et al. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–161. doi: 10.1046/j.1351-8216.2003.00832.x
  • Baronciani L, Peyvandi F. How we make an accurate diagnosis of von Willebrand disease. Thromb Res. 2020;196:579–589. doi: 10.1016/j.thromres.2019.07.010
  • James PD, Goodeve AC. von Willebrand disease. Genet Med. 2011;13(5):365–376. doi: 10.1097/GIM.0b013e3182035931
  • Lee SJ. Re: Request for new ICD-10-CM codes for von Willebrand disease. 2020 [cited 2022 Dec 12]. Available from: https://www.hematology.org/-/media/hematology/files/advocacy/testimony-and-correspondence/2020/ash-letter-re-wvd-icd-10-codes.pdf
  • Schaefer J, Lehne M, Schepers J, et al. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15(1):145. doi: 10.1186/s13023-020-01424-6
  • Konrad R, Zhang W, Bjarndottir M, et al. Key considerations when using health insurance claims data in advanced data analyses: an experience report. Health Syst (Basingstoke). 2019;9(4):317–325. doi: 10.1080/20476965.2019.1581433
  • Komodo. Healthcare map: the most complete view of the patient. 2022 [cited 2022 Dec 12]. Available from: https://www.komodohealth.com/technology/healthcare-map
  • Baser O, Samayoa G, Yapar N, et al. Use of open claims vs closed claims in health outcomes research. J Health Econ Outcomes Res. 2023;10(2):44–52. doi: 10.36469/jheor.2023.87538
  • Roberts JC, Christopherson PA, Morateck PA, et al. A von Willebrand factor (VWF) functional screening assay and its correlation with conventional clinical assays of VWF function. Blood. 2014;124(21):4239. doi: 10.1182/blood.V124.21.4239.4239
  • Bucciarelli P, Siboni SM, Stufano F, et al. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels. J Thromb Haemost. 2015;13(2):228–236. doi: 10.1111/jth.12799
  • Brown MC, White MH, Friedberg R, et al. Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease. Res Pract Thromb Haemost. 2021;5(4):e12513. doi: 10.1002/rth2.12513
  • Djukic SM, Lekovic D, Jovic N, et al. Unnecessary hysterectomy due to menorrhagia and disorders of hemostasis: an example of overuse and excessive demand for medical services. Front Pharmacol. 2016;7:507. doi: 10.3389/fphar.2016.00507
  • Guncar G, Kukar M, Notar M, et al. An application of machine learning to haematological diagnosis. Sci Rep. 2018;8(1):411. doi: 10.1038/s41598-017-18564-8
  • Roberts JC, Malec LM, Halari I, et al. Bleeding patterns in patients before and after diagnosis of von Willebrand disease: analysis of a US medical claims database. Haemophilia. 2022;28(1):97–108. doi: 10.1111/hae.14448
  • Jacobson AE, Vesely SK, Koch T, et al. Patterns of von Willebrand disease screening in girls and adolescents with heavy menstrual bleeding. Obstet Gynecol. 2018;131(6):1121–1129. doi: 10.1097/AOG.0000000000002620
  • Spradbrow J, Letourneau S, Grabell J, et al. Bleeding assessment tools to predict von Willebrand disease: utility of individual bleeding symptoms. Res Pract Thromb Haemost. 2020;4(1):92–99. doi: 10.1002/rth2.12256